Search clinical trials for: Hybrid Closed Loop (HCL)

Total 7045 results

Centre Hospitalier Sud Francilien

Completed

Real-world Use of Hybrid Closed Loop in Adolescents and Young Adults 15-25 Years of Age With Type 1 Diabetes (BFHado)

Type1 Diabetes | Adolescents | Young Adults

France
Texas Tech University
Texas Tech University Health Science Center

Recruiting

Naltrexone for Prolonged Grief Disorder (NPGD)

Placebo | Naltrexone HCl 50 MG Oral Tablet

United States
University of Virginia
Juvenile Diabetes Research Foundation

Completed

Hybrid Closed-Loop Control With Smart Prandial Insulin Dosing in Type 1 Diabetes

Type 1 Diabetes

United States
University of Minnesota

Completed

Systemic Markers of Inflammation: 9- and 12-Month Follow-Up Post Non-Surgical Periodontal Therapy

Biomarkers | SRP | Minocycline HCl Microspheres

United States
University of Minnesota
Bausch Health Companies, INC.

Completed

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

Biomarkers | SRP | Minocycline HCl Microspheres

United States
Emory University
Jaeb Center for Health Research; Insulet Corporation

Completed

Automated Insulin Delivery for INpatients With DysGlycemia (AIDING) Feasibility

Diabetes Mellitus

United States
Acologix, Inc.

Unknown

A Randomized-Withdrawal Phase 3 Study Evaluating the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch) (AC120-8231)

Uremic Pruritus
Medtronic Diabetes

Completed

Overnight Closed Loop Study in U.S. (OCL)

Type 1 Diabetes

United States
Sunovion

Completed

Rifampin Drug-Drug Interaction Study With Lurasidone HCl

Male, Healthy Normal Subjects

United States
Hospices Civils de Lyon

Completed

Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience.

Acute Myeloid Leukemia

France
Memorial Sloan Kettering Cancer Center
Cephalon

Completed

Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma

Lymphoma | Hodgkin's Disease

United States
Jurgen Barth

Completed

Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab

Hairy Cell Leukemia (HCL)

Germany
University of Virginia
DexCom, Inc.; Tandem Diabetes Care, Inc.

Completed

Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Using Total Daily Insulin

Type 1 Diabetes Mellitus

United States
iN Therapeutics Co., Ltd.

Recruiting

A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients.

Pain | Osteoarthritis | Chronic Pain | Neuropathic Pain | Post Herpetic Neuralgia

Australia
University of Virginia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation

Type 1 Diabetes

United States
Derrick Scott Robertson
University of South Florida; Genzyme, a Sanofi Company

Terminated

Rapid Elimination Procedure of Teriflunomide With Colestipol Hydrochloride (TERCOL)

Healthy Volunteers | Teriflunomide Elimination

United States
Johnson & Johnson Pharmaceutical Research & Development...
ALZA; Sequus Pharmaceuticals

Terminated

CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy

Ovarian Neoplasms
Ondokuz Mayıs University

Completed

Aesthetic Efficacy of Resin Infiltration Using Different Conditioning Methods: 24-Month Results

White Spot Lesion

Turkey
Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Recruiting

Study of ZG0895.HCl in Patients With Advanced Solid Tumors

Advanced Solid Tumor

China
Amgen

Completed

Bone Biopsy Study For Dialysis Patients With Secondary Hyperparathyroidism of End Stage Renal Disease (BONAFIDE)

Secondary Hyperparathyroidism

United States, Italy, Belgium, Switzerland, Hungary, Spain, Turkey, Poland, Portugal, United Kingdom, Czech Republic, Macedonia, The Former Yugoslav Republic of
Hospices Civils de Lyon

Completed

EBV-associated Diffuse Large B Cell Lymphoma

To Characterize and Compare Clinical, Pathological and Molecular Features

France
University Hospital, Grenoble

Completed

SAFETIM-needs : Exploring Adolescent's and Parent's Needs During Transition in French CF Centers (SAFETIM-needs)

Cystic Fibrosis | Adolescent Behavior

France
Taro Pharmaceuticals USA

Completed

Evaluate the Clinical Equivalence of Two Naftifine HCl 1% Creams in Patients With Interdigital Tinea Pedis

Tinea Pedis
Hospices Civils de Lyon

Recruiting

Anxiety Related to the Diagnosis of Alzheimer's Disease or Related Diseases (ADIMA)

Cognitive Decline

France
Emmanuel Boselli

Completed

Prediction of Immediate Postoperative Pain Using Analgesia/Nociception Index (ANI)

Postoperative Pain

France
Hospices Civils de Lyon

Recruiting

Muscle Function and Physical Activity in the Modern Era of Cystic Fibrosis (MUCOMUSCLE)

Cystic Fibrosis

France
University Hospital, Grenoble
Hospices Civils de Lyon

Completed

Impact of Interictal Electroencephalographic Abnormalities on the Stability of Attention in the Epilepsies (COGNIT-AIC)

Epilepsy

France
Hôpital Edouard Herriot

Completed

Prediction of Hemodynamic Reactivity During General Anesthesia Using Analgesia/Nociception Index (ANI)

Anesthesia

France
University of Kansas Medical Center
National Cancer Institute (NCI)

Completed

Acolbifene in Preventing Cancer in Premenopausal Women at High Risk of Breast Cancer

Breast Cancer

United States
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions

To Determine Bioequivalence Under Fed Conditions

Canada
Cambridge Antibody Technology

Unknown

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Leukemia | Hairy Cell Leukemia | HCL

United States, Poland, United Kingdom
Alza Corporation, DE, USA

Completed

Bioequivalence Between Integrated E-TRANS (Fentanyl) System and Separated (Two-Part) E-TRANS (Fentanyl) System

Pain, Postoperative
Daiichi Sankyo, Inc.

Completed

Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS) (ENLIVEN)

Tenosynovial Giant Cell Tumor | Pigmented Villonodular Synovitis | Giant Cell Tumors of the Tendon Sheath

United States, France, Australia, Denmark, Spain, Netherlands, Germany, Canada, United Kingdom, Hungary, Italy, Poland
BioCryst Pharmaceuticals

Completed

Phase II Study of Forodesine in Subjects With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia (CLL)

United States, Australia
Hospices Civils de Lyon

Withdrawn

Assessing the Impact of a Call Center Providing Standardized Pediatric Advice (PLATEL-EVAL) (PLATEL-EVAL)

Emergency Pediatric Care

France
Hospices Civils de Lyon

Recruiting

Clinical-immunological Features of DNER Ataxia (CLIMDA)

DNER Ataxia

France
Hospices Civils de Lyon

Recruiting

Lyon Registry of Stroke Treated by Thrombolysis or Thrombectomy (RELATE)

Ischemic Stroke

France
Daiichi Sankyo, Inc.

Completed

Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin

Type 2 Diabetes | Hyperlipidemia

United States
Janssen Korea, Ltd., Korea

Completed

An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back Pain

Low Back Pain
Astellas Pharma Global Development, Inc.

Completed

A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

Relapsed Lymphoid Malignancy | Refractory Lymphoid Malignancy

United States, Canada
Hospices Civils de Lyon

Completed

Early Dry Cohort : Impact on the Fluid Balance of a Perfusion Based Protocol to Adjust UFnet During Deresuscitation in Intensive Care Unit. (Early Dry)

Acute Kidney Injury

France
Par Pharmaceutical, Inc.
Phoenix International Life Sciences, Inc.

Completed

Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions

To Determine Bioequivalence Under Fasting Conditions

Canada
Centre Hospitalier de Bourg en Bresse
Hospices Civils de Lyon; Direction Générale de l'Offre de Soins

Recruiting

EXtubation With SUctioning or With Positive End-Expiratory Pressure in Intensive Care Unit (EXSUPEEP)

Extubation in Intensive Care Unit

France
Boston Medical Center
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Not yet recruiting

Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 Diabetes

Diabetes Complications | Diabetes Mellitus, Type 1

United States
Phoenix Neurological Associates, LTD

Completed

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) (PNA)

Amyotrophic Lateral Sclerosis

United States
Axoltis Pharma
ACT4ALS network

Not yet recruiting

ALS Phase II Study of NX210c (SEALS)

Amyotrophic Lateral Sclerosis

France
Hospices Civils de Lyon

Active, not recruiting

BCL6-rearrangements Implications in Non-Hodgkin Lymphomas. (BCL6-RINHL)

Follicular Lymphoma | Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma

France
Centre Hospitalier Universitaire de Saint Etienne

Completed

Cracking the Code of Crying Babies: How Familiarity Changes the Interpretation of Cries (BEBEDOL)

Magnetic Resonance Imaging | Neuronal Activity

France
Emmanuel Boselli

Completed

Prediction of Hemodynamic Reactivity During Suspension Laryngoscopy Using Analgesia/Nociception Index (ANI)

Anesthesia

France
Hospices Civils de Lyon

Not yet recruiting

Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus (PENCIL)

Systemic Lupus Erythematosus

France

Search clinical trials for: Hybrid Closed Loop (HCL)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations